Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Date Issued
2018
Author(s)
Dreger, Peter
Michallet, Mauricette
Bosman, Paul
Dietrich, Sascha
Sobh, Mohamad
Boumendil, Ariane
Nagler, Arnon
Scheid, Christof
Cornelissen, Jan
Niederwieser, Dietger
Müller, Lutz
Vandenberghe, Elizabeth
Scortechini, Ilaria
Schoemans, Helene
Andersen, Niels S.
Finke, Jürgen
Russo, Domenico
Ljungman, Per
Passweg, Jakob
van Gelder, Michel
Durakovic, Nadira
Labussiere-Wallet, Helene
Berg, Tobias
Bethge, Wolfgang
Bunjes, Donald
Stilgenbauer, Stefan
Canepari, Maria Elisa
Schaap, Michel
Fox, Christopher P.
Kröger, Nicolaus
Montoto, Silvia
DOI
10.1038/s41409-018-0207-4